Patient Pathfinder: Clinical Trials
Clinical Trials for Ovarian Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 440 active Ovarian Cancer trials
Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer
Study Type: Interventional Phase 1
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Study Type: Interventional Phase 2
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
Study Type: Interventional Phase 1
Etigilimab and Nivolumab for the Treatment of Platinum-Resistant Recurrent Clear Cell Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Study Type: Interventional Phase 2
Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
Study Type: Interventional Phase 2
Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass
Study Type: Observational
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Study Type: Interventional Phase 3
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer
Study Type: Interventional Phase 2
There are 440 active Ovarian Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now